Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9814692 Fumarate ester dosage forms

Patent 9814692 was granted and assigned to Banner Life Sciences (company) on November, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Banner Life Sciences (company)

0

Current Assignee

Banner Life Sciences (company)

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Tanesha Roberts0

Aqeel A. Fatmi0

Jason M. Vaughn0

Justin R. Hughey0

Sunil Agnihotri0

Tatyana Dyakonov0

Date of Patent

November 14, 2017

0

Patent Application Number

153861750

Date Filed

December 21, 2016

0

Patent Citations Received

US Patent 12083107 Pharmaceutical compositions comprising glitazones and Nrf2 activators

0

US Patent 11903918 Fumarate ester dosage forms with enhanced gastrointestinal tolerability

0

Patent Primary Examiner

Abigail Vanhorn

0

Patent abstract

Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof. In particular, oral controlled release pharmaceutical compositions comprising fumarate esters suspended in liquid matrices are described. One embodiment described herein is a pharmaceutical composition comprising fumarate esters suspended in a lipid or lipophilic liquid with enhanced bioavailability.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9814692 Fumarate ester dosage forms

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool